Company Filing History:
Years Active: 2000
Title: **The Innovative Contributions of Ming Fai Chim in Nail Fungal Treatment**
Introduction
Ming Fai Chim, an inventor based in San Francisco, CA, has made significant strides in the field of pharmacology with her innovative approach to treating nail fungal diseases. With one patent to her name, Chim has developed a unique topical formulation that offers an effective solution for those suffering from this common ailment.
Latest Patents
Chim's notable patent centers around stable, topical formulations designed for the treatment of nail fungal diseases. The disclosed composition comprises an antifungal compound alongside at least one pharmaceutically acceptable excipient that is adequate to formulate a gel. The specific formula involves an antifungal compound where R1, R2, and R3 can independently be hydrogen or lower alkyl; X represents --(CH2)n, where n equals 0, 1, or 2; Y denotes aryl or heteroaryl; and Ar also signifies aryl or heteroaryl. This formulation is applied to the affected nail once a day until the fungal disease is completely cured.
Career Highlights
Ming Fai Chim works at Bertek Pharmaceuticals, Inc., where she has dedicated her efforts to the research and development of dermatological therapies. Her breakthrough patent showcases her expertise in crafting effective pharmaceutical solutions, which has potential benefits for a significant number of individuals affected by nail fungal issues.
Collaborations
In her career, Chim has collaborated with esteemed colleagues such as Bhaskar Chaudhuri and Daniel Bucks. Together, they contribute to advancements in pharmaceutical science, enhancing the effectiveness of treatments available in the market.
Conclusion
Ming Fai Chim's contribution to the treatment of nail fungal diseases is a testament to her innovative spirit and commitment to improving patient care. Her patented formulation not only paves the way for better therapeutic options but also highlights the important role of inventors in the healthcare industry.